Facetten
Zugriff
Einrichtung
Medientyp
- Text 3
Karte
Erscheinungsjahr
Autor/in
- Blauvelt, Andrew
- Gordon, Kenneth B
- Foley, Peter 2
- Madden, Cynthia 2
- Papp, Kim A 2
- alle zeigen
Sprache
- Englisch 3
3 Einträge gefunden
-
Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial
- Gordon, Kenneth B
- Foley, Peter
- Krueger, James G
- Pinter, Andreas
- Reich, Kristian
- Vender, Ronald
- Vanvoorden, Veerle
-
Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trial
- Reich, Kristian
- Papp, Kim A
- Blauvelt, Andrew
- Langley, Richard G
- Armstrong, April
- Warren, Richard B
- Gordon, Kenneth B
-
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials
- Gordon, Kenneth B
- Strober, Bruce
- Lebwohl, Mark
- Augustin, Matthias
- Blauvelt, Andrew
- Poulin, Yves
- Papp, Kim A